Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2005
10/13/2005US20050227326 Obtaining vector comprising a modified PLAC4 having a mutation in one or more Pribnow box-like sequences into which gene encoding target protein has been inserted; reduction in gene expression when vector is cloned in bacteria; transformation
10/13/2005US20050227325 Recombinant polynucleotide
10/13/2005US20050227324 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment
10/13/2005US20050227321 Producing antimicrobial peptides (AMPs) by using microbes; not necessary to offset the positive charges of multiple copies of AMPs in multimeric constructs; enables the use of a wider range of multimers and carrier peptides
10/13/2005US20050227318 Site-specific incorporation of redox active amino acids into proteins
10/13/2005US20050227316 Using restriction enzyme digestion and ligase sealing to generate vector comprising preferential gene sequences; directed protein evolution
10/13/2005US20050227314 selectively splitting the polypeptide at a Cys-His site, by hydrolysis in presence of a palladium promotor dissolved in formic acid; purification with by-product inhibition
10/13/2005US20050227313 Polypeptide cleavage process
10/13/2005US20050227312 Method for gene expression
10/13/2005US20050227291 cyclic peptide consisting of three genetically encodable amino acid residues,at least one of said amino acid residues is a serine, threonine, or cysteine; employed in a variety of research and medical applications, including methods of treating a patient for hepatitis C infection.
10/13/2005US20050227287 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPSc
10/13/2005US20050227282 Human extracellular matrix-1
10/13/2005US20050227281 Using immobilized oligonucleotides as tools in synthesis, selection, amplification and evolution of non-natural molecules based on nucleic acid templates
10/13/2005US20050227280 Proteases
10/13/2005US20050227273 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
10/13/2005US20050227272 Isolated nucleic acid with polynucleotide encoding a polypeptide that interacts with I kappa B alpha probe; diagnosis or pre-diagnosis of Type 1 diabetes in an individual
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227063 Plasmon nanoparticles and pixels, displays and inks using them
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050224076 Aerosol generation device and inhalation device therewith
10/13/2005DE60104282T2 Lösliche mutante ctla4 moleküle und deren verwendung Soluble CTLA4 mutant molecules and their use
10/13/2005CA2561702A1 Methods for altering protein production rates
10/13/2005CA2559827A1 Filamentous fungal mutants with improved homologous recombination efficiency
10/13/2005CA2545512A1 Methods of identifying neoplasm-specific antibodies and uses thereof
10/12/2005EP1584628A2 Viral protein
10/12/2005EP1584058A2 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein
10/12/2005EP1583823A2 Isolation and identification of cross-reactive t cells
10/12/2005EP1583558A2 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
10/12/2005EP1583512A2 Methods of producing lignin peroxidase and its use in skin and hair lightening
10/12/2005EP1468012A4 Biomolecule transduction motif mph-1-btm and the use thereof
10/12/2005EP1417237A4 Process for preparation of polypeptides of interest from fusion peolypeptides
10/12/2005EP1339867A4 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
10/12/2005EP1261732B1 Manufacture and purification of cyclosporin a
10/12/2005EP1046038B1 Use of mass fingerprinting for identification of protein affinity ligands
10/12/2005EP0669979B1 C-c ckr-1, c-c chemokine receptor
10/12/2005EP0556345B2 Retroviral vectors useful for gene therapy
10/12/2005CN1681838A Nogo受体拮抗剂 Nogo receptor antagonist
10/12/2005CN1681833A Sir2 products and activities
10/12/2005CN1681527A Therapies for renal failure using interferon-beta
10/12/2005CN1680581A Single clone antibody of antimutagen hepatitis B virus surface antigen
10/12/2005CN1680580A Preparation of inhibiting peptide of tonin
10/12/2005CN1680579A Separation of soya polypeptide, protein peptone and amino acid by biological fermentation
10/12/2005CN1680578A Preparation of oyster bioactive peptide
10/12/2005CN1680577A Preparation of amino acid polypeptide composite liquid from forest frog muscle
10/12/2005CN1680566A Pseudomycin production by pseudomonas syringae
10/12/2005CN1680558A Recommbined D-amino acid oxidase
10/12/2005CN1680557A Penicillium marneffei CRG5 gene, its coding protein and use
10/12/2005CN1680555A Penicillium marneffei 60S ribosomal protein L33-B, its coding sequence and use
10/12/2005CN1680554A Penicillium marneffei thymus resistant glubolin, its coding sequence and use
10/12/2005CN1680451A Immune responses against HPV antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
10/12/2005CN1680447A Neutralizing high affinity human monoclonal antibodies specific to respiratory syncytial virus f-protein
10/12/2005CN1680443A Recombinat protein containing albumin multimer
10/12/2005CN1680434A Streptococcus pneumoniae antigens
10/12/2005CN1680432A Viral protein
10/12/2005CN1680426A Purification method which prevents denaturation of an antibody
10/12/2005CN1222618C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
10/12/2005CN1222617C Chemotactic factor receptos 88-2B [CKR-3] and 88C and their antibodies
10/12/2005CN1222616C Novel human protein with cancer-inhibiting function and coding sequence thereof
10/12/2005CN1222540C Monoclonal antibodies anti-CD6 and their uses
10/12/2005CN1222539C Human receptor proteins, related reagents and methods
10/11/2005USRE38825 Genes encoding a glyphosate oxidoreductase enzyme; useful in producing transformed bacteria and plants which degrade glyphosate herbicide; crop plants which are tolerant to glyphosate herbicide
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953837 Factor VIII/vWF complexes and compositions
10/11/2005US6953835 Coleopteran toxin proteins of bacillus thuringiensis
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953675 Landscaped antibodies and antibody fragments for clinical use
10/11/2005US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin
10/11/2005US6953667 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
10/11/2005CA2341276C Human anti-factor ix/ixa antibodies
10/11/2005CA2087272C Cd53 cell surface antigen and use thereof
10/09/2005CA2501624A1 Cloning and expression of gonadotropin-releasing hormone (gnrh) receptors
10/06/2005WO2005093103A2 Development and use of fluorescent probes of unbound analytes
10/06/2005WO2005093073A1 Exo-endo cellulase fusion protein
10/06/2005WO2005093069A2 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells
10/06/2005WO2005093066A1 Marker gene for arthrorheumatism test
10/06/2005WO2005093057A1 Truncated dance, dance complex and method of using these
10/06/2005WO2005093056A1 Process for producing dipeptide
10/06/2005WO2005093040A1 Eukaryotic cells expressing phycocyanin
10/06/2005WO2005092916A1 Novel fermentation products
10/06/2005WO2005092914A1 Process for promoting proper folding of human serum albumin using a human serum albumin ligand
10/06/2005WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/06/2005WO2005091751A2 Novel gene associated with type 1 diabetes and methods of use
10/06/2005WO2005077090A3 Improved methods of producing antibody conjugates
10/06/2005WO2005034876A3 Use of cell lines to produce active therapeutic proteins
10/06/2005WO2004076618A9 Genetically modified non-human mammals and cells
10/06/2005WO2004041193A3 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5
10/06/2005US20050223433 Cobra gene and uses thereof
10/06/2005US20050223430 Gntiii expression in plants
10/06/2005US20050223422 Vector with a pormoter to modulate in vivo and in vitro transcription of a polynucleotide; with first and second nucleic acid molecules which are heterologous to each other
10/06/2005US20050222386 Biomolecule transduction motif sim-2-btm and the use thereof
10/06/2005US20050222033 Receptor based antagonists and methods of making and using
10/06/2005US20050222011 Selectin ligands
10/06/2005US20050221447 Mannosyl transfer with regeneration of GDP-mannose
10/06/2005US20050221444 Expression cassette comprising a polypeptide with a promoter sequence, a translation initiation sequence, a first inclusion body fusion partner, suppressable stop codon,cleavable peptide linkers, a fusion tag, and a transcription terminator sequence; antidiabetic agents; viral infections
10/06/2005US20050221443 Tumor necrosis factor super family agonists
10/06/2005US20050221442 Bacterial host cell for the direct expression of peptides
10/06/2005US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft
10/06/2005US20050221438 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for grafting enhancement, graft versus host (GvH) inhibition, graft versus tumor (GvT) stimulation, for the prevention or therapy of tumors and/or of microorganism infections
10/06/2005US20050221436 Human neuropeptide Y-like G protein-coupled receptor
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 1125